Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease

Authors

Alexander Ngwube, Pheonix Children's Hospital
Niketa Shah, Yale University
Kamar Godder, Nicklaus Children's Hospital
David Jacobsohn, Children's National Medical Center, Washington, DC
Monica L. Hulbert, Washington University School of Medicine in St. Louis
Shalini Shenoy, Washington University School of Medicine in St. Louis

Journal

Blood Advances

Publication Date

2020

Volume

4

Issue

16

First Page

3894

Last Page

3899

Document Type

Open Access Publication

DOI

10.1182/bloodadvances.2020002236

Rights and Permissions

Alexander Ngwube, Niketa Shah, Kamar Godder, David Jacobsohn, Monica L. Hulbert, Shalini Shenoy; Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease. Blood Adv 2020; 4 (16): 3894–3899. doi: https://doi.org/10.1182/bloodadvances.2020002236

Recommended Citation

Ngwube, Alexander; Shah, Niketa; Godder, Kamar; Jacobsohn, David; Hulbert, Monica L.; and Shenoy, Shalini, "Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease." Blood Advances. 4, 16. 3894 - 3899. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9613